EGFR and neoplasm: For instance, although isolated TERT mutants carry a poor prognosis (see Fig. 6 and other studies116,118), a TERT wildtype paired with EGFR amplification and MGMT methylation yielded poorer prognoses than many other tumour genetic communities, including many of those exhibiting TERT promotor mutants.